Fatigue. Officers and managers should always apply the “Health and Safety and Fatigue Management” principles outlined in clause 76 of this Agreement. This is particularly the case: ▪ where officers have worked for extended periods; ▪ where two officer stations have been reduced to one officer; ▪ where officers are covering neighbouring divisions; and ▪ at one officer stations generally. Management will always endeavour to provide cover for any officer on a 10-hour fatigue break.
Fatigue. An Employee must notify his or her supervisor at the start of the shift if the Employee is taking prescription drugs which may cause Impairment. If an Employee has any concerns regarding their fitness for work or the fitness for work of another person, the Employee must notify their supervisor immediately. The Company is committed to providing safe systems of work and eliminating hazards in the workplace. This includes taking reasonable precautions to ensure all Employees are in a fit state to work so as to minimise the risk of injury to Employees and others. All Employees will be subject to alcohol and drug testing both at the commencement of their employment, as part of the Company’s selection process, and throughout their employment in accordance with the Company’s Fitness for Work Policy. Employees will also be subject to the Company’s Drug and Alcohol Policy, and will undergo drug and alcohol testing in accordance with the procedures contained in that policy. A positive result to these tests may result in disciplinary action, including termination of employment, in accordance with the Fitness for Work Policy. 3 Restrictions on work for another employer
Fatigue. Persons with conditions that could result in sudden or subtle incapacitation, such as epilepsy, heart disease, uncontrolled diabetes mellitus, cannot be medically certified according to CAR 424. Conditions such as anaemia, acute infection or peptic ulcers are temporarily disqualifying.
Fatigue. 1. It is the Flight Attendant’s responsibility to report properly rested and prepared for all assignments. It is understood that there will be times and circumstances in which Flight Attendants may become fatigued to the extent that alertness and/or performance becomes a safety of flight concern. In situations where fatigue could create an unsafe operation, it is the Flight Attendant's responsibility to remove themselves from, or decline, the duty assignment. It is Company policy to remove a Flight Attendant from a flight assignment once a claim of fatigue is made. All claims of fatigue will be subsequently reviewed to ascertain and/or validate the cause(s).
Fatigue chill, and/or dizziness, which may diminish my/our reaction time and increase the risk of accident.
Fatigue. 1. The Company recognizes that a Flight Attendant may reach a point, as a result of work- related duties, where he/she feels that his/her physical state is such that the required duties could not be performed safely during flight. In such circumstances, the Flight Attendant will notify the captain of the flight and Crew Scheduling and will be removed from the remaining legs of the trip (without pay for those legs pending Fatigue Review Board decision) and put into rest. The Flight Attendant must submit a report via WBAT within twenty-four (24) hours from the end of the rest period to explain the circumstances which gave rise to the fatigue.
Fatigue. A physiological state of reduced mental or physical performance capability resulting from lack of sleep or increased physical activity that can reduce a Flight Attendant’s alertness and ability to safely perform safety-related duties.
Fatigue. Feeling tired; lack of energy; tiring easily
Fatigue. (a) Fatigue risk management for Engineers is detailed in SEP-019.
Fatigue. Fatigue is common in rheumatoid arthritis (RA) and its absence characterises disease remission [Pinals et al. 1981]. Qualitative studies have highlighted the importance people with RA attribute to fatigue and RA patients believe reducing fatigue should be a key treatment aim [Xxxx et al. 2003; Xxxxxx et al. 2005] and patients regard fatigue as a major determinant of their quality of life [Xxxx et al. 2004] and disability [Xxxxx et al. 2005]. Between 40-80% of RA patients attending specialist clinics have clinically relevant fatigue, which is a feature of active disease. [Xxxxx 1995; Xxxxx et al. 1993; Xxxxxx et al. 1981; Xxxxx et al. 1996] By contrast few cases (under 5%) are in remission [Xxxxx et al. 2004], in which there is no fatigue. These observations suggest disease activity is one underlying factor, in the pathogenesis of fatigue in RA. Surprisingly the ways in which disease activity influence RA fatigue has not been investigated to any extent. However, interest in this issue has been stimulated by a large randomised controlled trial (RCT) of adalimumab, an anti-TNF agent, which significantly reduced fatigue in RA [Xxxxxxxxx et al. 2003]. The improvement in fatigue was associated with falls in disease activity, providing the best evidence yet that inflammatory synovitis is a potentially important causal factor for RA fatigue. There is relatively little data on whether conventional disease modifying anti-rheumatic drugs (DMARDs) reduce fatigue. Only one RCT has looked at this to any extent. It compared leflunomide with methotrexate and showed both DMARDs improved SF-36 energy and vitality scores, which are equivalent to fatigue measured with specific instruments [Strand et al. 2005]. Several other factors influence RA fatigue, including psychosocial factors, health beliefs, illness perceptions and poor social support [Xxxxxx et al. 1998; Xxxxxxx et
